Skip to content
Screener

Vivani Medical VANI Q4 2025 Annual earnings

Reported March 26, 2026

EPS-$0.09In line
EPS estimate-$0.09

Next report

Nov 12, 2026 (in 2 months)
EPS estimate-$0.07

Financials

Q4 2025

Income statement

See full
Operating income-$6.8M-5.4%
Net income-$6.6M-9.6%
EPS (diluted)-$0.09+18.2%

Balance sheet

See full
Cash & equivalents$15.4M-21.7%
Total debt$18.9M-2.4%
Total equity$15.7M-10.7%
Total assets$39.4M-5.2%

Cash flow

See full
Operating cash flow-$6.7M-15.6%
CapEx$274.0K-7.4%
Free cash flow-$7.0M-14.5%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$89.73M+30.6%
Enterprise value$93.16M+36.3%

Returns & leverage

See full
Return on equity-159.6%+69.7pp
Debt / equity1.2×+0.1×
Current ratio2.7×-0.7×

FAQ

When did Vivani Medical report Q4 2025 earnings?
Vivani Medical (VANI) reported Q4 2025 earnings on March 26, 2026.
What were Vivani Medical's Q4 2025 revenue and EPS?
Vivani Medical reported eps of $-0.09 for Q4 2025.
Did Vivani Medical beat estimates in Q4 2025?
EPS beat the consensus estimate of $-0.09 by $0.00.
How did Vivani Medical's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 18.2% from $-0.11.
Where can I find Vivani Medical's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001753926-26-000550) and the 10-K periodic report (0001753926-26-000548) directly on SEC EDGAR. The filing index links above go to sec.gov.